New Report Available: Jordan Pharmaceuticals & Healthcare Report Q2 2013
Although Jordan's pharmaceutical market is not as attractive as those of Israel and Lebanon in the Gulf Levant, we are broadly positive in our outlook for the sector where consumption is set to increase due to the growing population, increased urbanisation and incidence of noncommunicable diseases as well as swifter uptake of drugs. However, the biggest downside risk to investment is the country's relatively young population and lack of jobs, which will restrict purchasing power and medicines uptake. Limited employment...
View full press release